about
Nanoparticles for Improving Cancer Diagnosis.Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.Protein-Adsorbed Magnetic-Nanoparticle-Mediated Assay for Rapid Detection of Bacterial Antibiotic Resistance.Gd-encapsulated carbonaceous dots with efficient renal clearance for magnetic resonance imaging.X-Ray Induced Photodynamic Therapy: A Combination of Radiotherapy and Photodynamic TherapyIron oxide nanoparticle encapsulated diatoms for magnetic delivery of small molecules to tumorsFe5C2 nanoparticles with high MRI contrast enhancement for tumor imaging.Label-free luminescent mesoporous silica nanoparticles for imaging and drug delivery.One-step synthesis of monodisperse and hierarchically mesostructured silica particles with a thin shell.Glycine-assisted hydrothermal synthesis of peculiar porous alpha-Fe2O3 nanospheres with excellent gas-sensing properties.One-step synthesis of functional chiral porous silica nanorods using an achiral surfactant.Fine control over the morphology and structure of mesoporous silica nanomaterials by a dual-templating approach.Porous magnetic manganese oxide nanostructures: Synthesis and their application in water treatmentRapid evaporation-induced synthesis of monodisperse budded silica spheresConjugation of a Scintillator Complex and Gold Nanorods for Dual-Modal Image-Guided Photothermal and X-ray-Induced Photodynamic Therapy of TumorsInterplay of Nanoparticle Rigidity and Its Translocation Ability through Cell MembraneMagnetic Manganese Oxide Sweetgum-Ball Nanospheres with Large Mesopores Regulate Tumor Microenvironments for Enhanced Tumor NanotheranosticsChromium-Doped Zinc Gallogermanate@Zeolitic Imidazolate Framework-8: A Multifunctional Nanoplatform for Rechargeable In Vivo Persistent Luminescence Imaging and pH-Responsive Drug ReleaseAcridine Orange Encapsulated Mesoporous Manganese Dioxide Nanoparticles to Enhance RadiotherapyHollow mesoporous carbon nanospheres for imaging-guided light-activated synergistic thermo-chemotherapy
P50
Q30442412-32BB692C-4ECA-48EC-9410-C142A8EA84CAQ36056202-347E1B4D-D7F7-4656-863D-823B96E912ACQ36278888-A7705748-FA6B-480A-A7C8-704F2F6C5F21Q36948085-877F5DDE-C8E8-4096-AE6F-34D606BCC7D9Q37427803-D390CCB5-1918-4A4B-9EB5-A686E87A06D7Q37682638-E5A3ADED-27B7-407F-AD18-AF5056565D85Q39041958-373FBA2D-BC0C-4DAD-9479-C8B1F444B260Q39093813-4322FBCF-8D66-4FBD-BA18-DC30DC1280DDQ42942757-2AADD6EE-44E5-4199-A24D-8D520D1C8DF6Q43183634-A57F85C7-1797-451C-A9F6-3A37322E62CBQ43293620-95CE49EA-4953-4309-ABC2-AB5FED81E21FQ46358837-71F4048F-519C-499C-B05C-A25E05D4A69FQ57363664-C4366A54-0102-4AB4-8F4F-9884E5408DD9Q81329898-FBFE2826-5166-47F2-BA6A-45032BAAC50BQ89915855-98B953E1-3710-45B9-9E18-537A896D35ECQ90363420-2B85889A-2CD5-4C7A-AA43-B8C929640AB8Q90435916-6A29C9F7-6394-4E24-BCBB-914DEAC7082AQ90634153-4D87C3F6-9FEC-4B7C-96E1-4BD190977290Q91753618-B4D57223-228E-400B-B51C-FAD76AB5A2F0Q92742565-AFECBED2-8E8E-4091-A0E1-DCCE49E3DFD3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hongmin Chen
@ast
Hongmin Chen
@en
Hongmin Chen
@es
Hongmin Chen
@nl
Hongmin Chen
@sl
type
label
Hongmin Chen
@ast
Hongmin Chen
@en
Hongmin Chen
@es
Hongmin Chen
@nl
Hongmin Chen
@sl
prefLabel
Hongmin Chen
@ast
Hongmin Chen
@en
Hongmin Chen
@es
Hongmin Chen
@nl
Hongmin Chen
@sl
P1053
B-9555-2011
P106
P31
P3829
P496
0000-0002-6699-2300